12:00 AM
 | 
Mar 08, 2010
 |  BC Week In Review  |  Company News  |  Deals

Molecular Targeting Technologies, University of Notre Dame deal

Molecular Targeting received an exclusive, worldwide license to the university's phosphatidylserine targeting molecule and related technology. The molecule, which selectively targets dead and dying...

Read the full 107 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >